Showing 2451-2460 of 5771 results for "".
- Katena Products Announces the Acquisition of Blink Medicalhttps://modernod.com/news/katena-products-announces-the-acquisition-of-blink-medical/2480044/Katena Products announced the purchase of Blink Medical, a UK-based provider of primarily single use ophthalmic instruments. Terms of the deal were not announced. Founded in 2004, Blink Medical currently distributes its products within Europe and the Middle East.
- Wills Eye Hospital Announces $5 Million Gift for Vision Researchhttps://modernod.com/news/wills-eye-hospital-announces-5-million-gift-for-vision-research/2480046/Wills Eye Hospital has announced that a gift of $5 million has been made to the hospital by philanthropists Vickie and Jack Farber to create the Vickie and Jack Farber Vision Research Center at Wills Eye. The gift builds on their
- Abom Announces Sales Alliance with Essilor Prescription Safety Eyewear for RX with Advanced Anti-Fog Technologyhttps://modernod.com/news/abom-announces-sales-alliance-with-essilor-prescription-safety-eyewear-for-rx-with-advanced-anti-fog-technology/2480049/Abom, a manufacturer of anti-fogging heated goggles with integrated rechargeable batteries, announced the newest addition to its line of products, the Abom HEET RX goggle anti-fog solution. The HEET RX features the second generation of Abom’s award-winning heated goggle technology, improving upon
- Ocular Therapeutix Announces NDA Resubmission of Dextenzahttps://modernod.com/news/ocular-therapeutix-announces-nda-resubmission-of-dextenza/2480054/Ocular Therapeutix has announced the resubmission of the company’s new drug application (NDA) to the FDA for its lead product candidate Dextenza (dexamethasone insert) 0.4mg, for the treatment of ocular pain following ophthalmic surgery. The resubmission is intended to address manufacturing defic
- Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Hydra-Peg Custom Contact Lens Coatinghttps://modernod.com/news/bausch-lomb-announces-licensing-agreement-with-tangible-science-for-use-of-hydra-peg-custom-contact-lens-coating/2480063/Bausch + Lomb announced that it has entered into a worldwide licensing agreement with Tangible Science, allowing Bausch + Lomb to offer the Tangible Hydra-PEG advanced contact lens coating technology for use with several of its Boston gas permeable (GP) materials and scleral lenses. Terms
- Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45 Million Public Offering of Common Stockhttps://modernod.com/news/aerpio-pharmaceuticals-announces-uplisting-to-nasdaq-capital-market-and-pricing-of-45-million-public-offering-of-common-stock/2480066/Aerpio Pharmaceuticals announced that its common stock will begin trading on the Nasdaq Capital Market under the symbol “ARPO” at the opening of trading on June 26, 2018, following its previously announced approval to list its common stock on the Nasdaq Capital Market. Aerpio also announce
- Staar Surgical and Kobe Kanagawa Eye Clinic in Japan Announce Strategic Cooperation Agreementhttps://modernod.com/news/staar-surgical-and-kobe-kanagawa-eye-clinic-in-japan-announce-strategic-cooperation-agreement/2480068/Staar Surgical and Kobe Kanagawa Eye Clinic, with locations in Tokyo and Osaka, announced they have entered into a multi-year Strategic Cooperation Agreement to provide Staar’s EVO Visian ICL lenses as a primary and premium option for patients seeking visual freedom from spectacles and cont
- Iridex Announces Multiple Studies of MicroPulse Laser Therapy Published at WOChttps://modernod.com/news/iridex-announces-multiple-studies-of-micropulse-laser-therapy-published-at-woc/2480069/Iridex announced new data was released at the World Ophthalmology Congress in Barcelona showing that MicroPulse Laser Therapy with the MicroPulse P3 Glaucoma Device is safe and effective. New real-world data shows a reduction in IOP close to 50%, with new morphological i
- EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financinghttps://modernod.com/news/eyepoint-pharmaceuticals-announces-stockholder-approval-of-second-tranche-of-capital-financing/2480070/EyePoint Pharmaceuticals announced that it has received stockholder approval for the second tranche of growth capital under a Securities Purchase Agreement (Second Tranche Transaction) with Essex Woodland (EW) Healthcare Partners, a healthcare-focused investment firm; Rosalind Advisors; and anoth
- Glaukos Announces FDA Approval for the iStent inject Trabecular Micro-Bypass Systemhttps://modernod.com/news/glaukos-announces-fda-approval-for-the-istent-inject-trabecular-micro-bypass-system/2480073/Glaukos announced it has received premarket approval from the FDA for the »iStent inject Trabecular Micro-Bypass System, which is indicated for the reduction of IOP in adult